Leah Sanchez
Neurology with Special Qualifications in Child Neurology · Montgomery, ALNPI 1518077965
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 260 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by UCB, Inc. at 41.8% of the total. Reporting peaked in 2023 at $960 and has fallen 97.0% since, to $29 in 2025. That places this record below the midpoint for neurology with special qualifications in child neurology clinicians in AL, where the typical reported total is $4,193.
Across 260 payments — averaging $16.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$2K
- Sunovion Pharmaceuticals Inc.$683
- Eisai Inc.$370
- Supernus Pharmaceuticals, Inc.$250
- Catalyst Pharmaceuticals, Inc.$249
- Jazz Pharmaceuticals Inc.$140
- plus $746 from 19 others
What the payments were for
- Food & beverage$4,193100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 114 | $1,754 |
| Sunovion Pharmaceuticals Inc. | 41 | $683 |
| Eisai Inc. | 23 | $370 |
| Supernus Pharmaceuticals, Inc. | 22 | $250 |
| Catalyst Pharmaceuticals, Inc. | 10 | $249 |
| Jazz Pharmaceuticals Inc. | 6 | $140 |
| Sumitomo Pharma America, Inc. | 9 | $107 |
| Aquestive Therapeutics, Inc. | 6 | $97 |
| Amgen(2 entities) | 3 | $77 |
| Acadia Pharmaceuticals Inc | 3 | $55 |
| Neurelis, Inc. | 3 | $54 |
| Argenx US, Inc. | 3 | $53 |
| SK Life Science, Inc. | 2 | $45 |
| Immedica Pharma US, Inc. | 1 | $29 |
| Boston Scientific | 2 | $29 |
| Scilex Pharmaceuticals Inc. | 2 | $28 |
| Greenwich Biosciences, Inc. | 2 | $23 |
| AstraZeneca | 1 | $23 |
| Genentech USA, Inc. | 1 | $21 |
| Tanabe Pharma America, Inc. | 1 | $21 |
| Livanova USA, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Aprecia Pharmaceuticals, LLC | 1 | $18 |
| Zogenix Inc. | 1 | $15 |
| Upsher-smith Laboratories LLC | 1 | $13 |
How this compares
$4,193 in reported general payments places this provider in the 50th percentile of 24 neurology with special qualifications in child neurology providers in Alabama.
See all neurology with special qualifications in child neurology providers in Alabama →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rufinamide | 14 | $30,280 |
| ValtocoDiazepam | 16 | $10,817 |
| Levetiracetam | 17 | $453 |
| Clonazepam | 13 | $164 |
| Lamotrigine | 12 | $157 |
| Pregabalin | 14 | $120 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurelis, Inc.Valtoco | $54 | $10,81716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 24 neurology with special qualifications in child neurology providers in Alabama.
Other neurology with special qualifications in child neurology in Montgomery
- Alyssa ReddyBirmingham$68K
- Alan PercyBirmingham$51K
- Kimberly LimboHuntsville$43K
- Michael LopezBirmingham$22K
- Elizabeth BebinBirmingham$15K
- Amitha AnanthBirmingham$10K
- Paul MaertensMobile$10K
- Ahmad Al-HamdaMuscle Shoals$8K
- Jan MathisenBirmingham$8K
- Monisha GoyalBirmingham$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.